MONOPHARMA
Mono Pharmacare financials
- Market cap
- ₹16 Cr
- Sector
- Healthcare
What Mono Pharmacare Ltd does
Mono Pharmacare Limited is a healthcare-sector company headquartered in Ahmedabad, Gujarat, listed on the NSE SME Emerge platform under the symbol MONOPHARMA. Its operations are closely tied to a group of related entities — including Supal Pharma, Supal Pharmacare Ltd, Supal Medical & Wholesale LLP, Ahmedabad Medical Corporation, Supal Distributors LLP and Supal Trading LLC-Dubai — with which it carries out sale/purchase transactions of goods in the ordinary course of business. The company holds a 99% stake in two associate entities, Ahmedabad Medical Corporation and Supal Distributors LLP, which operate in the same line of business. Its FY25 annual report records nil energy-conservation, technology-absorption and foreign-exchange activity, consistent with a trading/distribution rather than manufacturing operating model.
- Associate/distribution entities
- 2 (99% stake each — Ahmedabad Medical Corporation, Supal Distributors LLP)
- Geographic footprint
- Domestic operations only — nil foreign exchange earnings/outgo in FY25
Quarterly results
Q4 FY26: revenue up 76.8%, net profit down 100.0% against the same quarter last year.
| Line item | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 35 | 67 | 56 | 87 | 81 +131% | 66 −1% | 99 +77% |
| EBITDA | 2 | 4 | 2 | 5 | 3 +50% | 2 −50% | 2 +0% |
| Net profit | 1 | 2 | 1 | 2 | 1 +0% | 0 −100% | 0 −100% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −61.9% 1Y
1Y: ₹23.5 on 10 Sept 2025 → ₹8.95. High ₹24.45 (15 Sept 2025), low ₹7.6 (10 Aug 2026).
Balance sheet
| Year ending | FY23 | FY24 | FY25 |
|---|---|---|---|
| Equity capital | ₹12 Cr | ₹18 Cr | ₹18 Cr |
| Reserves | ₹1 Cr | ₹10 Cr | ₹14 Cr |
| Borrowings | ₹40 Cr | ₹41 Cr | ₹55 Cr |
| Other liabilities | ₹9 Cr | ₹12 Cr | ₹33 Cr |
| Total liabilities | ₹63 Cr | ₹81 Cr | ₹119 Cr |
| Fixed assets | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹61 Cr | ₹80 Cr | ₹118 Cr |
| Total assets | ₹63 Cr | ₹81 Cr | ₹119 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Sep 2025
The ownership split has held steady since Sep 2024. The shareholder count grew 11% to 514.
- Promoters
- 56.7%
- Public
- 43.3%
Since Sep 2024
- Promoters 0.00 pp
- Public 0.00 pp
How it drifted, 6 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 56.7%, Public 43.3%.Dec '23: Promoters 56.7%, Public 43.3%.Mar '24: Promoters 56.7%, Public 43.3%.Sep '24: Promoters 56.7%, Public 43.3%.Mar '25: Promoters 56.7%, Public 43.3%.Sep '25: Promoters 56.7%, Public 43.3%.
Who bought this quarter
since Mar 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- L7 Hitech Private Limited +0.98 pp 2.29% held
- Manish Upendra Shanghvi +0.19 pp 1.27% held
- Yogeshkumar Rasiklal Sanghavi +0.11 pp 1.63% held
- Thermo Capital Private Limited +0.09 pp 2.33% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Sep 2025 filing
Every holder of Mono Pharmacare Ltd above SEBI's 1% disclosure line, and what changed since Mar 2025.
| Holder | Stake | Change |
|---|---|---|
| Lakhatariya Panilam | 45.43% | unchanged |
| Supal Panilam Lakhatariya | 11.28% | unchanged |
| Harshad Rasiklal Sheth | 3.68% | unchanged |
| Thermo Capital Private Limited | 2.33% | +0.09 pp |
| L7 Hitech Private Limited | 2.29% | +0.98 pp |
| Prashil Sanjay Shah | 1.79% | unchanged |
| Yogeshkumar Rasiklal Sanghavi | 1.63% | +0.11 pp |
| Shah Amee T | 1.28% | unchanged |
| Manish Upendra Shanghvi | 1.27% | +0.19 pp |
| Bhawanji Keshavji Chheda | 1.13% | unchanged |
| Pallaviben Suhasbhai Shah | 0.00% | unchanged |
| Archit Shah | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Mono Pharmacare Ltd
Guides on how to read this kind of business and the numbers that matter.